Metabolic Syndrome Is Associated With Rapid Estimated Glomerular Filtration Rate Decline In A Chinese Community-Based Population

被引:13
作者
Wu, Zhongli [1 ]
Jiang, Yimeng [1 ]
Jia, Jia [1 ]
He, Danmei [1 ]
Sun, Pengfei [1 ]
Li, Jianping [1 ]
Huo, Yong [1 ]
Fan, Fangfang [1 ]
Zhang, Yan [1 ]
机构
[1] Peking Univ, Dept Cardiol, Hosp 1, Beijing 100034, Peoples R China
基金
中国国家自然科学基金;
关键词
metabolic abnormalities; estimated glomerular filtration rate; kidney function; atherosclerosis; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; RENAL-FUNCTION; RISK; PREVALENCE; NICOTINE;
D O I
10.2147/DMSO.S217326
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: This study aimed to determine the relationship between the metabolic syndrome (MetS) and rapid estimated glomerular filtration rate (eGFR) decline in a Chinese community-based population. Patients and methods: A total of 3108 participants were recruited between December 2011 and July 2014 from an observational study cohort designed for the study of atherosclerotic diseases in Beijing, China. The outcome was a rapid eGFR decline. Subgroup and interaction analyses were performed with respect to a number of covariates. Results: Over a median follow-up period of 2.34 (IQR: 2.29-2.41) years, the overall incidence of rapid eGFR decline was 7.24%. We found that the MetS was significantly associated with the risk of rapid eGFR decline (odds ratio [OR]=1.69, 95% confidence interval [CI]: 1.28-2.23, p<0.001) in a model adjusted for age, sex, and eGFR, and this relationship remained significant after adjustment for smoking, drinking, and low-density lipoprotein-cholesterol (OR=1.78, 95% CI: 1.34-2.35, p<0.001). Waist circumference (OR=1.38, 95% CI: 1.04-1.83, p=0.027), triglycerides (OR=1.40, 95% CI: 1.05-1.86, p=0.022), blood pressure (OR=2.05, 95% CI: 1.49-2.82, p<0.001), and fasting plasma glucose (OR=2.12, 95% CI: 1.57-2.85, p<0.001), but not high-density lipoprotein-cholesterol (OR=1.26, 95% CI: 0.94-1.69, p=0.117), were positively associated with the risk of rapid eGFR decline. Similarly, an increase in the number of MetS components present was associated with an increase in the risk of rapid eGFR decline. Furthermore, this association was modified by smoking status (OR=3.78, 95% CI: 1.68-8.49, p-interaction=0.030). Conclusion: The MetS independently predicted rapid eGFR decline in a Chinese community-based cohort recruited for the study of atherosclerosis. The relationship between the MetS and the risk of rapid eGFR decline was modified by smoking status.
引用
收藏
页码:2085 / 2092
页数:8
相关论文
共 33 条
[21]   Metabolic syndrome, but not insulin resistance, is associated with an increased risk of renal function decline [J].
Li, Youbao ;
Xie, Di ;
Qin, Xianhui ;
Tang, Genfu ;
Xing, Houxun ;
Li, Zhiping ;
Xu, Xiping ;
Xu, Xin ;
Hou, Fanfan .
CLINICAL NUTRITION, 2015, 34 (02) :269-275
[22]   The Association between Individual and Combined Components of Metabolic Syndrome and Chronic Kidney Disease among African Americans: The Jackson Heart Study [J].
Mendy, Vincent L. ;
Azevedo, Mario J. ;
Sarpong, Daniel F. ;
Rosas, Sylvia E. ;
Ekundayo, Olugbemiga T. ;
Sung, Jung Hye ;
Bhuiyan, Azad R. ;
Jenkins, Brenda C. ;
Addison, Clifton .
PLOS ONE, 2014, 9 (07)
[23]   Metabolic Syndrome, ESRD, and Death in CKD [J].
Navaneethan, Sankar D. ;
Schold, Jesse D. ;
Kirwan, John P. ;
Arrigain, Susana ;
Jolly, Stacey E. ;
Poggio, Emilio D. ;
Beddhu, Srinivasan ;
Nally, Joseph V., Jr. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (06) :945-952
[24]   Cigarette smoke condensate aggravates renal injury in the renal ablation model [J].
Odoni, G ;
Ogata, H ;
Viedt, C ;
Amann, K ;
Ritz, E ;
Orth, SR .
KIDNEY INTERNATIONAL, 2002, 61 (06) :2090-2098
[25]   The number of metabolic syndrome components is a good risk indicator for both early- and late-stage kidney damage [J].
Okada, R. ;
Yasuda, Y. ;
Tsushita, K. ;
Wakai, K. ;
Hamajima, N. ;
Matsuo, S. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (03) :277-285
[26]   Induction of Oxidative Stress in Kidney [J].
Ozbek, Emin .
INTERNATIONAL JOURNAL OF NEPHROLOGY, 2012, 2012
[27]   Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan [J].
Saito, Takako ;
Mochizuki, Toshio ;
Uchida, Keiko ;
Tsuchiya, Ken ;
Nitta, Kosaku .
HEART AND VESSELS, 2013, 28 (03) :323-329
[28]   Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study [J].
Sidorenkov, Oleg ;
Nilssen, Odd ;
Brenn, Tormod ;
Martiushov, Sergey ;
Arkhipovsky, Vadim L. ;
Grjibovski, Andrej M. .
BMC PUBLIC HEALTH, 2010, 10
[29]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[30]   Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis [J].
Thomas, George ;
Sehgal, Ashwini R. ;
Kashyap, Sangeeta R. ;
Srinivas, Titte R. ;
Kirwan, John P. ;
Navaneethan, Sankar D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10) :2364-2373